https://media.wired.com/photos/677dc6c1e07e9236bd865d2c/191:100/w_1280,c_limit/feature_novostill.jpg
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?
WIRED
2025-01-13 11:00:00